SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

Bitmine Immersion Technologies Inc

Bitmine Immersion Technologies ($BMNR) is trending following its annual shareholder meeting, where a major equity investment in MrBeast's Beast Industries has ignited sharp debate among investors. While some view this as a strategic 'moonshot' for broad crypto exposure to younger demographics, a significant portion of the community expresses concern over the company's core Ethereum treasury strategy, perceived dilution, and leadership's decisions.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending following reports of robust early demand for its recently launched oral Wegovy pill, which is amplified by a regulatory delay for a key competitor's oral obesity treatment. This development gives Novo Nordisk a significant first-mover advantage in the burgeoning oral GLP-1 market, driving community discussion around the drug's "game-changing" potential and the company's strong growth prospects.

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Holdings Inc

The upcoming Investor Day for Ondas Holdings is generating significant buzz, with the community highly anticipating potential announcements regarding a major contract, updated 2026 financial outlook, and a rumored spin-off of its drone division, following a substantial $1 billion capital raise. Investors are keenly watching how this capital and strategic government tenders will impact the company's trajectory, fueling fervent debate between expectations of significant upside and concerns over market manipulation and "sell the news" events. Amidst geopolitical tensions highlighting demand for drone and defense technologies, discussions center on whether Ondas Autonomous Systems can deliver transformative news to solidify its position in the rapidly expanding sector.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is trending after being selected as an awardee for a significant defense contract, validating its innovative direct-to-smartphone satellite technology for both civilian and military applications. The community is actively celebrating the stock's recent surge past a key psychological price level, fueling widespread discussion about a potential short squeeze and its long-term disruptive potential in global telecommunications, despite ongoing debates about its valuation as a pre-revenue company.

Regentis Biomaterials Ltd. engages in the development of tissue repair solutions. It focuses on orthopedic treatments through its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue such as inflamed cartilage and bone tissue. The company was founded by Dror Seliktar and Tal Yehiel on September 1, 2004 and is headquartered in Or-Akiva, Israel.

Regentis Biomaterials Ltd.

Regentis Biomaterials

Regentis Biomaterials ($RGNT) is gaining significant attention due to its extremely low public float and a recently secured U.S. patent for its GelrinC liquid formulation, which many believe was initially overlooked. The community is actively discussing the stock's potential for a strong upward movement, driven by its limited tradable shares and insider lock-up, generating anticipation for increased volume and price action for this recent IPO.

Springview Holdings Ltd. engages in the design and construction of residential and commercial buildings. It involves new construction, reconstruction, alterations, and other general contracting services. The company was founded in 2002 and is headquartered in Singapore.

Springview Holdings Ltd - Ordinary Shares - Class A

Springview Holdings Ltd

Springview Holdings (SPHL) is trending after a massive surge, driven by news of its international expansion into solar-ready homes in Singapore. The community is actively discussing its low-float status and short-squeeze potential, drawing comparisons to other recent parabolic movers, with some traders reporting brokerage limitations on buying.

Moolec Science SA engages in the development and production of science-based food ingredients. Its products include pet food, animal feed, and dietary supplements. The company was founded by Gastón Paladini, Henk Hoogenkamp, and Martin Salinas in 2020 and is headquartered in George Town, Cayman Islands.

Moolec Science SA

Moolec Science (MLEC) is experiencing significant market attention following its recent reverse stock split, which drastically reduced its tradable share float. This has ignited community discussion positioning it as a speculative low-float play, with many drawing comparisons to other stocks that have seen explosive short squeezes. Traders are keenly watching its high volatility and the potential for rapid price movements should momentum and volume persist.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is seeing a surge in attention following multiple analyst upgrades and its established position as a critical national security space partner through major government defense contracts. The community is actively bullish, celebrating impressive gains and eagerly anticipating milestones like the Neutron rocket's maiden flight, even amidst ongoing discussions about its valuation in a rapidly expanding sector.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending due to robust Phase 2 data for its obesity drug VK2735 and heightened M&A speculation following Novo Nordisk's CEO expressing openness to multi-billion dollar acquisitions in the weight-loss sector. The community is actively debating VKTX's 

High Roller Technologies, Inc. is an evolving and growth-oriented iCasino and entertainment company, which engages in the business of operating an online gaming business offering casino betting games to customers. The firm also offers a wide range of games including many that are available in land-based casinos, such as blackjack, roulette, baccarat, poker, and slot machines. The company was founded by Michael Alexander Cribari and Brandon Christopher Eachus on December 21, 2021 and is headquartered in Las Vegas, NV.

High Roller Technologies Inc.

High Roller Technologies Inc

High Roller Technologies is trending after signing a binding Letter of Intent with crypto.com/us to enter the burgeoning U.S. event-based prediction markets, a sector projected to reach a trillion dollars. The community is highly engaged, discussing the stock's low float and massive upside potential, drawing comparisons to other recent high-volatility runners. This strategic move into a rapidly expanding industry is fueling strong investor interest and speculative momentum.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Anixa Biosciences (NASDAQ:ANIX) Issues Earnings Results, Meets Expectations

Anixa Biosciences (NASDAQ:ANIX - Get Free Report) posted its earnings results on Monday. The company reported ($0.09) earnings per share (EPS) for the quarter, hitting the consensus estimate of...

Anixa Biosciences Inc (NASDAQ:ANIX) Given Average Recommendation of "Hold" by Brokerages

Shares of Anixa Biosciences Inc (NASDAQ:ANIX - Get Free Report) have been assigned an average rating of "Hold" from the five brokerages that are currently covering the stock, MarketBeat Ratings...

Anixa Biosciences (ANIX) Expected to Announce Quarterly Earnings on Friday

Anixa Biosciences (NASDAQ:ANIX) will be releasing its Q4 2025 earnings before the market opens on Friday, January 9. (View Earnings Report at...

Anixa Biosciences Inc (NASDAQ:ANIX) Sees Significant Increase in Short Interest

Anixa Biosciences Inc (NASDAQ:ANIX - Get Free Report) saw a large increase in short interest in December. As of December 15th, there was short interest totaling 795,400 shares, an increase of 40.7...

Anixa Biosciences (NASDAQ:ANIX) Stock Rating Lowered by Wall Street Zen

Wall Street Zen downgraded shares of Anixa Biosciences from a "hold" rating to a "sell" rating in a report on Saturday...

Anixa Biosciences (NASDAQ:ANIX) Given "Buy" Rating at D. Boral Capital

D. Boral Capital reaffirmed a "buy" rating and issued a $10.00 price target on shares of Anixa Biosciences in a research note on Friday...

Anixa Biosciences Shares Jump Over 15% In After-Hours Trading Here's Why

Anixa Biosciences shares surged in after-hours trading after presenting clinical trial data for its investigational breast cancer vaccine.read more...

Anixa Biosciences Announces Positive Phase 1 Data for Investigational Breast Cancer Vaccine; Primary Endpoints Were Met and Immune Response Observed in 74% of Participants

Anixa Biosciences Announces Positive Phase 1 Data for Investigational Breast Cancer Vaccine; Primary Endpoints Were Met and Immune Response Observed in 74% of Participants Anixa Biosciences Announces...

Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Monday, December 15, 2025

Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Monday, December 15, 2025 Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Monday, December 15, 2025...

Anixa Biosciences (NASDAQ:ANIX) Stock Rating Lowered by Zacks Research

Zacks Research downgraded Anixa Biosciences from a "strong-buy" rating to a "hold" rating in a research note on Tuesday...

Anixa Biosciences, Inc. is a biotechnology company, which engages in the development of therapies and vaccines focused on oncology. It operates through the following segments: Cancer Vaccines, CAR-T Therapeutics, and Other. The Cancer Vaccines segment includes the early stages development of immunization for breast and ovarian cancer. The CAR-T Therapeutics segment is involved in the development of immuno-therapy drugs against cancer. The Other segment refers to its legacy operations, including patent licensing. The company was founded on November 5, 1982 and is headquartered San Jose, CA.

Anixa Biosciences Inc

Short-Term Volatility, Then Markets Move On

Sustained Risk-Off Until Fed Path Is Clear

Little Impact — Fundamentals Still Rule

Other – Comment Below

Markets pulled back after reports that the DOJ opened a criminal investigation into Federal Reserve Chair Jerome Powell, raising concerns about central bank independence. With rate cuts, inflation, and political pressure all in focus, how do you think this standoff will impact markets in 2026?

How Will the Powell Investigation Impact Markets in 2026?

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$0.09	--	--	N/A
Q4 '25	-$0.09	--	--	N/A
Q3 '25	-$0.08	-$0.07	8.70%	BEAT
Q2 '25	-$0.09	--	--	N/A
Q1 '25	-$0.09	--	--	N/A

ANIX
Anixa Biosciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '26

Historical Earnings

Latest ANIX News

ANIXAnixa Biosciences Inc